NCT05188027 Aerobic vs Resistance Exercise in Post-menopausal Women With Type 1 Diabetes
| NCT ID | NCT05188027 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Type 1 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2021-11-16 |
| Primary Completion | 2027-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2021-11-16 with a primary completion date of 2027-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Participants will be asked to wear a continuous glucose monitor for at least three days on three separate occasions. One testing session will be a no-exercise resting control session (90 minutes). One will be a moderate aerobic exercise session (30 minutes of exercise, 60 minutes of recovery), and the third will be a moderate weight-lifting session (\~30 minutes of exercise, 60 minutes of recovery).The investigators will measure changes in blood glucose during exercise by drawing blood during and after exercise. Post-exercise glucose trends will be examined using continuous glucose monitoring.
Eligibility Criteria
Inclusion Criteria: * type 1 diabetes, diagnosed for at least one year * post-menopause (at least one year since last menstrual period), or have had a hysterectomy and bilateral salpingo oophorectomy * able to perform aerobic and resistance exercise * able to visit the lab in Edmonton, Alberta (University of Alberta) Exclusion Criteria: * HbA1c \> 9.9 % * frequent and unpredictable hypoglycemia * change in insulin management strategy within the last 2 months * blood pressure \> 140 / 95 * severe peripheral neuropathy * history of cardiovascular disease * musculoskeletal injuries interfering with exercise performance * use of medications (other than insulin) that affect glucose metabolism * BMI \> 30 kg/m2 * smoking * moderate to high alcohol intake (\> 2 drinks/day)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05188027 clinical trial?
This trial is open to female participants only, aged 45 Years or older, up to 75 Years, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05188027 currently recruiting?
Yes, NCT05188027 is actively recruiting participants. Contact the research team at jane.yardley@ualberta.ca for enrollment information.
Where is the NCT05188027 trial being conducted?
This trial is being conducted at Edmonton, Canada, Montreal, Canada.
Who is sponsoring the NCT05188027 clinical trial?
NCT05188027 is sponsored by University of Alberta. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.